Pharma Journalist 8769 posts 0 comments

AstraZeneca has strengthened its weight management and metabolic disease pipeline through a new strategic collaboration with CSPC Pharmaceuticals, targeting the development of multiple…
Read More...

AstraZeneca has announced a landmark $15 billion investment in China through 2030, significantly expanding its research, development, and manufacturing capabilities as part of its…
Read More...

Repertoire® Immune Medicines, a biotechnology company focused on programmable T cell–targeted immune medicines, has entered into a major strategic collaboration with Eli Lilly and…
Read More...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending conditional marketing authorisation for Rezurock…
Read More...

Otsuka Pharmaceutical Development & Commercialization, Inc., together with Otsuka Pharmaceutical Co., Ltd., has reached a key regulatory milestone after the U.S. Food and Drug…
Read More...

Simcere Pharmaceutical Group Ltd. and Boehringer Ingelheim have entered into a global license and collaboration agreement to develop SIM0709, a pre-clinical bispecific antibody designed…
Read More...

Insilico Medicine and Qilu Pharmaceutical Group have entered into a strategic partnership aimed at accelerating the discovery and development of new therapies for cardiometabolic…
Read More...

Mirum Pharmaceuticals, Inc. has completed its acquisition of Bluejay Therapeutics, a privately held biotechnology company focused on viral and liver diseases, marking a significant step…
Read More...

Eisai Co., Ltd. and Biogen Inc. have announced a key regulatory milestone for their Alzheimer’s disease therapy lecanemab-irmb, marketed in the United States as LEQEMBI®. The U.S. Food…
Read More...

WuXi Biologics and HanchorBio Inc. have announced a strategic collaboration aimed at accelerating the development and manufacturing of multiple next-generation bi- and multi-functional…
Read More...